Herein, we demonstrated that inhibition of COX-2, mPGES-1 and CYP4A by ISL decreased FGF-2, TGF-β and VEGF production, and blocked glioma angiogenesis. The gene discussed is PTGS2; the disease is central nervous system cancer.